tiprankstipranks
Corbus Pharmaceuticals announes data for CRB-701 from Western Dose study
The Fly

Corbus Pharmaceuticals announes data for CRB-701 from Western Dose study

Corbus Pharmaceuticals (CRBP) announced data from its first-in-human dose escalation clinical study conducted in the United States and the United Kingdom of CRB-701 will be presented at the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, to be held in San Francisco, CA February 13-15, 2025.

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App